PEOPLE - FibroGen (US) makes appointment:
This article was originally published in Clinica
Jack Anthony has been appointed to the new position of vice-president of business development of FibroGen, a US developer of human recombinant collagen for the woundcare market. Mr Anthony joins from Cell Therapeutics, a developer of molecular therapies for cancer, inflammatory and immune diseases.
You may also be interested in...
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.